[1]
Hiwa Khalid Qadir et al. 2022. Efficacy of Favipiravir in the Treatment of Mild to Moderate COVID-19 Patients in Erbil: A Controlled Clinical Trial. International Journal of Applied Sciences: Current and Future Research Trends . 13, 1 (May 2022), 228–235.